ANGPTL2 and Insulin resistance: Because we previously reported that deletion of ANGPTL2 reduces adipose tissue inflammation and systemic insulin resistance in dietary obesity (Tabata et al. 2009), we further investigated a possible role of ANGPTL2 in HFD‐induced adipose tissue remodeling.